DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ZILRETTA

« Back to Dashboard

All Clinical Trials for Zilretta

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT03529942	Study to Evaluate the Effect of FX006 on Synovial Inflammation in Patients With OA of the Knee	Recruiting	Flexion Therapeutics, Inc.	Phase 3	2018-04-24	This is an open-label study assessing the effect of the administration of a single intra-articular (IA) injection of FX006 32 mg on synovial volume in patients with osteoarthritis (OA) of the knee.
NCT03895840	The Effect of Intra-articular Bilateral Knee Injections of Zilretta on Performance Measures in Adults With Knee OA	Recruiting	University of Kansas Medical Center	Phase 4	2018-03-19	This study will be an open-label trial to determine the functional effects of bilateral IA injections of Zilretta into knee joints of 70 subjects with bilateral KL grade 2-4 symptomatic knee osteoarthritis (OA). Measurement and evaluation of outcomes at baseline, 6, 12 and 24 weeks will allow assessment of short and long-term effects, consistent with Osteoarthritis Research Society International (OARSI) and Outcome Measures in Rheumatology (OMERACT) recommendations.
NCT04160091	Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis	Recruiting	Medpace, Inc.	Phase 2	2019-11-07	This is a double-blind study to evaluate the efficacy and safety of FX006 in patients with glenohumeral osteoarthritis (OA) or shoulder adhesive capsulitis (AC).
NCT04160091	Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis	Recruiting	Flexion Therapeutics, Inc.	Phase 2	2019-11-07	This is a double-blind study to evaluate the efficacy and safety of FX006 in patients with glenohumeral osteoarthritis (OA) or shoulder adhesive capsulitis (AC).
NCT04182672	Study to Assess the Safety and Efficacy of FX006 Administered to Patients With Greater Trochanteric Bursitis	Not yet recruiting	Flexion Therapeutics, Inc.	Phase 2	2020-01-06	The purpose of this study is to determine the safety and efficacy of Zilretta (FX006) in bursal injections and to assess the patient's impression to change in treatments, to their chronic pain.
NCT04182672	Study to Assess the Safety and Efficacy of FX006 Administered to Patients With Greater Trochanteric Bursitis	Not yet recruiting	The University of Texas Health Science Center, Houston	Phase 2	2020-01-06	The purpose of this study is to determine the safety and efficacy of Zilretta (FX006) in bursal injections and to assess the patient's impression to change in treatments, to their chronic pain.

Clinical Trial Conditions for Zilretta

Condition Name

Condition Name for Zilretta
Intervention	Trials
Osteoarthritis, Knee	3
Adhesive Capsulitis	2
Knee Osteoarthritis	2
Osteoarthritis of the Shoulder	1

Condition MeSH

Condition MeSH for Zilretta
Intervention	Trials
Osteoarthritis, Knee	4
Osteoarthritis	4
Bursitis	3
Inflammation	1

Clinical Trial Locations for Zilretta

Trials by Country

Trials by Country for Zilretta
Location	Trials
United States	12
United Kingdom	1

Trials by US State

Trials by US State for Zilretta
Location	Trials
California	2
North Carolina	2
Illinois	1
Virginia	1
Kentucky	1

Clinical Trial Progress for Zilretta

Clinical Trial Phase

Clinical Trial Phase for Zilretta
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	1
Phase 2	4

Clinical Trial Status

Clinical Trial Status for Zilretta
Clinical Trial Phase	Trials
Not yet recruiting	4
Recruiting	4

Clinical Trial Sponsors for Zilretta

Sponsor Name

Sponsor Name for Zilretta
Sponsor	Trials
Flexion Therapeutics, Inc.	4
University of Virginia	1
Austin V Stone	1

Sponsor Type

Sponsor Type for Zilretta
Sponsor	Trials
Industry	6
Other	5